Patience the watchword as companies line up to put S3 visions to the test by Steve Jones March 30, 2021April 1, 2021 Several companies have begun exploring trial pathways with Cannvalate’s clinical research arm as they seek to […]
Major doubts remain as industry reacts to CBD down scheduling by Steve Jones September 10, 2020September 14, 2020
